22071-24071
Randomized phase III trial on postoperative chemoradiation in combination with an EGFR-antibody versus postoperative chemoradiation in head and neck squamous cell carcinoma (HNSCC) with high risk of locoregional recurrence (W. Budach, H.Langendijk)
design